The Challenging Anticoagulant Therapy in COVID19 Patient with Associated Coagulopathy

• Главные авторы: Raissa Virgy Rianda (Автор), Mohammad Subkhan (Автор), Aditya Doni Pradana (Автор), Fahrun Nisa'i Fatimah (Автор), Rama Azalix Rianda (Автор), Muhammad Perdana Airlangga (Автор), Muhammad Miftahussurur (Автор)
• Формат: ‌
• Опубликовано: Interna Publishing, 2021-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

COVID-19 became a widespread infectious disease in late 2019. Indonesia currently has the highest COVID-19 mortality rate in Asia, between 4-5 percent. Interestingly, COVID-19-associated coagulopathy characterized by an increase of several procoagulant factor levels, including fibrinogen and D-dimer...